close
close
migores1

AbbVie’s emraclidin: M4 agonist could become best-in-class in schizophrenia

Photo of Vaseline VaselineOctober 3, 2024
0 Less than a minute
AbbVie’s emraclidin: M4 agonist could become best-in-class in schizophrenia

AbbVie’s emraclidin: M4 agonist could become best-in-class in schizophrenia

Photo of Vaseline VaselineOctober 3, 2024
0 Less than a minute
Photo of Vaseline

Vaseline

Related Articles

Apogee Enterprises reports mixed Q2 results, plans acquisition By Investing.com

Apogee Enterprises reports mixed Q2 results, plans acquisition By Investing.com

October 7, 2024
Rubrik: Lots to love

Rubrik: Lots to love

September 10, 2024
To consolidate in the range 1.1100-1.1150 – ING

To consolidate in the range 1.1100-1.1150 – ING

September 24, 2024
Next week: US CPI, China bounces back, RBNZ to cut 50bp

Next week: US CPI, China bounces back, RBNZ to cut 50bp

October 5, 2024
Back to top button